Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of GBP 99.37 billion. The enterprise value is 133.72 billion.

Market Cap	99.37B
Enterprise Value	133.72B

Important Dates

The last earnings date was Tuesday, April 29, 2025.

Earnings Date	Apr 29, 2025
Ex-Dividend Date	May 9, 2025

Share Statistics

Current Share Class	5.69B
Shares Outstanding	n/a
Shares Change (YoY)	+0.97%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	5.68B

Valuation Ratios

The trailing PE ratio is 16.32 and the forward PE ratio is 7.80.

PE Ratio	16.32
Forward PE	7.80
PS Ratio	2.06
PB Ratio	1.42
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.16, with an EV/FCF ratio of 15.43.

EV / Earnings	21.96
EV / Sales	2.83
EV / EBITDA	7.16
EV / EBIT	10.62
EV / FCF	15.43

Financial Position

The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.69.

Current Ratio	1.26
Quick Ratio	0.88
Debt / Equity	0.69
Debt / EBITDA	2.55
Debt / FCF	5.56
Interest Coverage	5.57

Financial Efficiency

Return on equity (ROE) is 8.62% and return on invested capital (ROIC) is 6.52%.

Return on Equity (ROE)	8.62%
Return on Assets (ROA)	4.79%
Return on Invested Capital (ROIC)	6.52%
Return on Capital Employed (ROCE)	9.58%
Revenue Per Employee	595,698
Profits Per Employee	75,178
Employee Count	81,000
Asset Turnover	0.29
Inventory Turnover	1.47

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.73% in the last 52 weeks. The beta is 0.50, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	-19.73%
50-Day Moving Average	24.35
200-Day Moving Average	26.75
Relative Strength Index (RSI)	42.61
Average Volume (20 Days)	604,090

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.18

Income Statement

In the last 12 months, Pfizer had revenue of GBP 48.25 billion and earned 6.09 billion in profits. Earnings per share was 1.07.

Revenue	48.25B
Gross Profit	35.91B
Operating Income	12.70B
Pretax Income	5.71B
Net Income	6.09B
EBITDA	18.01B
EBIT	12.70B
Earnings Per Share (EPS)	1.07

Full Income Statement

Balance Sheet

The company has 13.38 billion in cash and 48.20 billion in debt, giving a net cash position of -34.82 billion.

Cash & Cash Equivalents	13.38B
Total Debt	48.20B
Net Cash	-34.82B
Net Cash Per Share	n/a
Equity (Book Value)	70.01B
Book Value Per Share	12.28
Working Capital	7.27B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 10.81 billion and capital expenditures -2.14 billion, giving a free cash flow of 8.67 billion.

Operating Cash Flow	10.81B
Capital Expenditures	-2.14B
Free Cash Flow	8.67B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 74.42%, with operating and profit margins of 26.33% and 12.62%.

Gross Margin	74.42%
Operating Margin	26.33%
Pretax Margin	11.82%
Profit Margin	12.62%
EBITDA Margin	37.34%
EBIT Margin	26.33%
FCF Margin	17.96%

Dividends & Yields

This stock pays an annual dividend of 1.32, which amounts to a dividend yield of 5.76%.

Dividend Per Share	1.32
Dividend Yield	5.76%
Dividend Growth (YoY)	0.03%
Years of Dividend Growth	1
Payout Ratio	121.49%
Buyback Yield	-0.97%
Shareholder Yield	4.91%
Earnings Yield	6.13%
FCF Yield	8.72%

Dividend Details

Stock Splits

The last stock split was on July 1, 1999. It was a forward split with a ratio of 3.

Last Split Date	Jul 1, 1999
Split Type	Forward
Split Ratio	3

Scores

Pfizer has an Altman Z-Score of 2.22. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.22
Piotroski F-Score	n/a